Indiana Senate Bill 282 signals an important shift in how a fast-growing segment of healthcare will be regulated and insured. For agents working in the medical professional liability space, the impact is on how risks are classified, underwritten and managed on behalf of insureds. At the center of the law are two themes: formal oversight of medical spas and increased scrutiny of compounded medications. Both have direct, practical implications for insureds operating in the aesthetics and wellness space.

A Changing Definition of the Insured Risk

One of the most important aspects of SB 282 is how it reshapes the identity of the insured. Many medical spas or day spas have historically viewed themselves as wellness or cosmetic businesses. The new law provides clarification of what is considered a “medical spa”. Beginning January 1, 2027, medical spas in Indiana must be registered with the state and operate under the supervision of a licensed medical provider. Each facility must designate a “responsible practitioner” who is accountable for medical oversight, compliance and patient safety.

From a coverage standpoint, this creates a clear shift for insureds that may be written under general liability or miscellaneous professional liability. This brings forth the need for medical malpractice coverage, and, where appropriate, consideration of participation in the Patient’s Compensation Fund.

Licensing & Regulatory Requirements: What Insureds Need to Know

SB 282 introduces a more formal regulatory framework that insureds must actively manage. This is where agents will likely see the most immediate impact with day-to-day client conversations. Medical spas are now required to register with the Medical Licensing Board of Indiana. That registration places them within a publicly accessible database and subjects them to ongoing oversight.The law requires that a medical spa designates a “responsible practitioner”. This person must be a licensed healthcare provider with prescriptive authority in Indiana and must spend sufficient time on-site at the medical spa. The position is usually held by a physician, nurse practitioner or physician assistant.

That practitioner carries responsibility for:

• Establishing and enforcing clinical protocols
• Supervising delegated procedures such as injections
• Ensuring staff are appropriately trained and credentialed
• Overseeing the use of medications, including compounded drugs
• Reporting qualifying adverse events to the state

From an insurance standpoint, it is important to ensure proper coverage is in place for the medical spa and the “responsible practitioner”. Policies may include exclusions, limitations or conditions tied to licensing status, scope of practice and regulatory compliance. If a claim occurs and the practice was not properly registered or lacked appropriate supervision, coverage could be challenged.

Documentation & Operational Controls

SB 282 requires timely reporting of adverse events to the board. This reinforces the need for clear records around who performed procedures and under what supervision. In practical terms, this means insureds should expect to formalize:

• Written protocols for each procedure
• Training and competency documentation for staff
• Informed consent forms that are specific to each treatment
• Logs of adverse events and follow-up actions

These are not just regulatory checkboxes—they are critical elements when defending a claim. Better documentation can support an insured’s position, or it can expose gaps if procedures are not consistently followed.

Compounded Medications & New Liability Exposure

Many medical spas utilize compounded medications such as semaglutide, tirzepatide and hormone therapies. SB 282 brings additional attention to how these drugs are sourced and used. For insureds, this introduces a new layer of scrutiny. They must demonstrate that compounded medications are obtained from reputable pharmacies, properly stored and administered in accordance with accepted medical standards.

From a liability perspective, claims may increasingly involve questions around:

• Where the drug was sourced
• Whether it was appropriate for the patient
• How it was stored and handled
• Whether informed consent addressed the nature of the compounded drugs

Even if a compounding pharmacy is implicated, the treating provider and facility are often named in litigation, making this exposure one that insureds should not overlook.

What This Means for Agents

SB 282 creates a defined framework for advising clients and an opportunity to have more substantive conversations around risk management. Here are some areas where your insureds may benefit from guidance:

• Whether their current policies accurately reflect their operations and staff
• How their licensing and supervisory structure affects coverage
• What carriers expect in terms of documentation and controls
• Whether they should consider PCF participation

As underwriting becomes more detailed, well-prepared submissions will be critical. Providing clarity around responsible practitioners, scope of services and operational protocols will help position accounts more favorably with carriers.

Timeline of Changes

Practical Takeaways

SB 282 is about bringing structure to a segment of healthcare that has grown quickly without consistent oversight. The impact is immediate and practical. Medical spas must register with the state, operate under licensed supervision and adopt more formal clinical and documentation standards. These changes influence not only compliance, but also how coverage is written, underwritten and ultimately how claims are evaluated.

For agents, this is an opportunity to step into a more consultative role. Helping clients understand the connection between regulatory compliance, licensing and insurance coverage will be key to protecting their businesses in this evolving environment.

We encourage you to read the full bill.

If you’d like help reviewing specific accounts or identifying markets, please contact a member of our Healthcare and Human Services team listed below.